These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27102953)

  • 1. Allosensitization does not alter post-transplant outcomes in pediatric patients bridged to transplant with a ventricular assist device.
    Castleberry C; Zafar F; Thomas T; Khan MS; Bryant R; Chin C; Morales DL; Lorts A
    Pediatr Transplant; 2016 Jun; 20(4):559-64. PubMed ID: 27102953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of anti-HLA antibodies associated with ventricular assist device use in pediatric patients: A United Network for Organ Sharing database analysis.
    Magdo HS; Schumacher KR; Yu S; Gajarski RJ; Friedland-Little JM
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28568969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes in sensitized heart transplant patients bridged with ventricular assist devices.
    Kidambi S; Mohamedali B; Bhat G
    Clin Transplant; 2015 Jun; 29(6):499-505. PubMed ID: 25773536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.
    Alba AC; Tinckam K; Foroutan F; Nelson LM; Gustafsson F; Sander K; Bruunsgaard H; Chih S; Hayes H; Rao V; Delgado D; Ross HJ
    J Heart Lung Transplant; 2015 May; 34(5):685-92. PubMed ID: 25638296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex.
    Yang J; Schall C; Smith D; Kreuser L; Zamberlan M; King K; Gajarski R
    J Heart Lung Transplant; 2009 Feb; 28(2):123-9. PubMed ID: 19201336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitisation and post-transplant course after the implantation of ventricular assist device.
    Malickaite R; Rucinskas K; Staneviciene A; Miniauskas S; Maneikiene V; Zuoziene G; Sirvydis V
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):339-42; discussion 342-3. PubMed ID: 19098066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
    Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
    J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
    Arnaoutakis GJ; George TJ; Kilic A; Weiss ES; Russell SD; Conte JV; Shah AS
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1236-45, 1245.e1. PubMed ID: 21839482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices.
    Fraser CD; Zhou X; Magruder JT; Suarez-Pierre A; Lui C; Grimm JC; Higgins R; Kilic A
    J Card Surg; 2019 Jun; 34(6):474-481. PubMed ID: 31045281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular assist device-associated anti-human leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation.
    O'Connor MJ; Menteer J; Chrisant MR; Monos D; Lind C; Levine S; Gaynor JW; Hanna BD; Paridon SM; Ravishankar C; Kaufman BD
    J Heart Lung Transplant; 2010 Jan; 29(1):109-16. PubMed ID: 20123248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device.
    Baran DA; Gass AL; Galin ID; Zucker MJ; Arroyo LH; Goldstein DJ; Prendergast T; Lubitz S; Courtney MC; Correa R; Chan M; Spielvogel D; Lansman SL
    J Heart Lung Transplant; 2005 Nov; 24(11):1886-90. PubMed ID: 16297796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of flow PRA on outcome in pediatric heart recipients in modern era: An analysis of the Pediatric Heart Transplant Study database.
    Das BB; Pruitt E; Molina K; Ravekes W; Auerbach S; Savage A; Knox L; Kirklin JK; Naftel DC; Hsu D;
    Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29144053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplant Outcomes for Congenital Heart Disease Patients Bridged With a Ventricular Assist Device.
    Bryant R; Rizwan R; Villa CR; Zafar F; Wells D; Chin C; Lorts A; Morales DL
    Ann Thorac Surg; 2018 Aug; 106(2):588-594. PubMed ID: 29723531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant.
    Ko BS; Drakos S; Kfoury AG; Hurst D; Stoddard GJ; Willis CA; Delgado JC; Hammond EH; Gilbert EM; Alharethi R; Revelo MP; Nativi-Nicolau J; Reid BB; McKellar SH; Wever-Pinzon O; Miller DV; Eckels DD; Fang JC; Selzman CH; Stehlik J;
    J Heart Lung Transplant; 2016 Aug; 35(8):1024-30. PubMed ID: 27316382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients.
    Morris AA; Cole RT; Veledar E; Bellam N; Laskar SR; Smith AL; Gebel HM; Bray RA; Butler J
    J Am Coll Cardiol; 2013 Dec; 62(24):2308-15. PubMed ID: 23994416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ventricular assist device-mediated sensitization in the bridge-to-heart-transplantation patient.
    Kwon MH; Zhang JQ; Schaenman JM; Cadeiras M; Gjertson DW; Krystal CA; Laks H; Ardehali A; Deng MC; Shemin RJ; Reed EF
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1161-6. PubMed ID: 25702320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients.
    Drakos SG; Kfoury AG; Long JW; Stringham JC; Fuller TC; Nelson KE; Campbell BK; Gilbert EM; Renlund DG
    Ann Thorac Surg; 2006 Sep; 82(3):889-93. PubMed ID: 16928502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosensitization and outcomes in pediatric heart transplantation.
    Mahle WT; Tresler MA; Edens RE; Rusconi P; George JF; Naftel DC; Shaddy RE;
    J Heart Lung Transplant; 2011 Nov; 30(11):1221-7. PubMed ID: 21821435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.